Biostatistics and Bioinformatics Shared Resource Frangoise Seillier-Moiseiwitsch, PhD and Subha Madhavan, PhD The Biostatistics and Bioinformatics Shared Resource (BBSR) provides the Lombardi Comprehensive Cancer Center (Lombardi) research investigators with expertise in the biostatistical and bioinformatics aspects of clinical basic science, and population science research projects. Statistical issues are considered at all levels of investigation from the design to the conduct of experiments, maintenance of data quality, and the analysis and interpretation of results. Bioinformatics pertains mainly to database construction and management as well as to the development of tools for data analysis and annotation. Specifically, the primary objectives ofthe BBSR are: 1. to collaborate with Lombardi investigators on the biostatistics/bioinformatics aspects of basic science, clinical, and population science research projects, especially those likely to lead to research grant support; 2. to participate effectively in the clinical trials program by providing biostatistics/bioinformatics input to the planning of all Lombardi clinical trials, by active membership on the Clinical Research Committee and providing biostatistical reviews of proposed protocols, and by the monitoring of all Lombardi trials through the Data and Safety Monitoring Committee; 3. to educate Lombardi investigators, staff and students in biostatistics/bioinformatics methodology for the planning, conduct, analysis and interpretation of cancer research studies; 4. to perform research in biostatistics/bioinformatics methodology on problems arising in collaborations with investigators on cancer research projects;and 5. to coordinate with GUMC Biomedical Informatics Centers and to implement a common user interface for all Lombardi shared databases. Members ofthe BBSR collaborate with Pi's in all six programs and with other shared resources, specifically the Clinical Research Management Office (CRMO), the Genomics and Epigenomics (GESR), and the Proteomics and Metabolomics (PMSR) Shared Resources as well as the shared resources dispensing tissue (FCR, CMESR and HTSR). During 2008, BBSR members provided consultations to 31 Lombardi investigators on 43 peer-reviewed and funded projects, 58 Lombardi investigators on 102 pilot, developmental and consulting projects, and 2 Lombardi investigators on 2 non- peer-reviewed, funded projects. Frangoise Seillier- Moiseiwitsch directs the BBSR with the help of Subha Madhavan who focuses on the bioinformatics area. In the description of the shared resource, we outline the major changes to the operation of the BBSR and its environment that have occurred since the last CCSG submission.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Georgetown University
United States
Zip Code
Bae, Woo Kyun; Yoo, Kyung Hyun; Lee, Ji Shin et al. (2015) The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER-positive breast cancers. Mol Carcinog 54:1172-80
Adams, Inez; Christopher, Juleen; Williams, Karen Patricia et al. (2015) What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2. J Cancer Educ 30:344-52
Butrick, Morgan; Kelly, Scott; Peshkin, Beth N et al. (2015) Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling. Genet Med 17:467-75
London, Laricca; Hurtado-de-Mendoza, Alejandra; Song, Minna et al. (2015) Motivators and barriers to Latinas' participation in clinical trials: the role of contextual factors. Contemp Clin Trials 40:74-80
Mays, Darren; Niaura, Raymond S; Evans, W Douglas et al. (2015) Cigarette packaging and health warnings: the impact of plain packaging and message framing on young smokers. Tob Control 24:e87-92
Zhi, Xiuling; Lin, Ling; Yang, Shaoxian et al. (2015) ?II-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin. Hepatology 61:598-612
Rush, Christina L; Darling, Margaret; Elliott, Maria Gloria et al. (2015) Engaging Latina cancer survivors, their caregivers, and community partners in a randomized controlled trial: Nueva Vida intervention. Qual Life Res 24:1107-18
Heckler, Mary Mazzotta; Riggins, Rebecca B (2015) ERR? splice variants differentially regulate cell cycle progression. Cell Cycle 14:31-45
Kim, B; Wang, S; Lee, J M et al. (2015) Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy. Oncogene 34:1083-93
Tong, Angie; Kelly, Scott; Nusbaum, Rachel et al. (2015) Intentions for risk-reducing surgery among high-risk women referred for BRCA1/BRCA2 genetic counseling. Psychooncology 24:33-9

Showing the most recent 10 out of 544 publications